|
|
|
|
|
|
|
|
|
|
|
Macular Degeneration Fact Sheets
The fact sheets on this page are in PDF format.  (Adobe Reader is required to view or print PDF documents)
 |
Macular Degeneration Treatments
Most of the common treatments described here impact wet macular degeneration. It is important to note that there is currently no specific treatment for dry macular degeneration; however, taking a specific high-dose formula of vitamins and mineral supplements (the "AREDS" formula) can significantly reduce the risk of progressing from intermediate dry macular degeneration to advanced or wet macular degeneration. Learn more...
|
 |
Healthy Living with Macular Degeneration
People who are visually impaired benefit from a healthy lifestyle that contributes to overall well-being. This includes regular exercise-adjusted to ensure safety-and a nutritious diet that may help protect remaining vision. Learn more...
|
 |
Macular Degeneration: Frequently Asked Questions
Age-related macular degeneration (AMD) is a common eye disease that causes deterioration of the macula, the central area of the retina. The retina is a paper-thin tissue at the back of the eye where light-sensitive cells send visual signals to the brain. Sharp, clear, straight-ahead vision, color, and fine detail are processed by the macula, and damage to this area results in blind spots and blurred or distorted vision. When the macula is damaged, many daily activities such as driving and reading become increasingly difficult. Read the answers to the most frequently asked question about this eye disease.
|
 |
Clinical Trial Information for Macular Degeneration
It can take many years for a potential treatment for macular degeneration to work its way from the laboratory to rigorous testing and, finally, approval by the U.S. Food and Drug Administration (FDA). The process begins in the lab with basic investigations using cells and specially bred animal models. Next, translational research moves the therapy to the human setting. Finally, the drug is tested on humans in clinical trials divided into three phases: I, II, and III. Learn more...
|
|
|
|